Stress Management and Resiliency Training (SMART) Integrated Into Treatment of Major Depression
1 other identifier
interventional
24
1 country
1
Brief Summary
The investigators are doing this research study to find out if the Stress Management and Resiliency Training (SMART) therapy will help subjects with their major depression treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Nov 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 29, 2016
CompletedFirst Submitted
Initial submission to the registry
September 6, 2017
CompletedFirst Posted
Study publicly available on registry
September 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2018
CompletedNovember 14, 2018
November 1, 2018
1.6 years
September 6, 2017
November 13, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Connor-Davidson Resilience Scale Score
The Connor-Davidson Resilience Scale (CD-RISC), a 25-item scale, was developed to measure resiliency. CD-RISC has been evaluated and has been found to have good internal consistency (α = .89), test-retest reliability (intraclass correlation coefficient = .87), and positive correlation with multiple related measures with ability to distinguish between participants with lesser and greater resilience. The scores can range from 0 to 100. The mean score in a general population sample was 80.7 and in psychiatric outpatients 68. A positive change with increasing scores will indicate improvement in resilience.
baseline, 8 weeks
Secondary Outcomes (5)
Change in Hamilton Rating Scale for Depression Score
baseline, 8 weeks
Change in Patient Health Questionnaire-9 Score
baseline, 8 weeks
Change in Quick Inventory of Depressive Symptoms Score
baseline, 8 weeks
Change in Generalized Anxiety Disorder-7 Score
baseline, 8 weeks
Change in Perceived Stress Scale Score
baseline, 8 weeks
Study Arms (1)
Depressed Subjects
EXPERIMENTALSubjects will undergo an 8 week behavioral program with Stress Management and Resiliency Training.
Interventions
Subjects will undergo an 8 week behavioral program. Treatment will consist of weekly group therapy sessions in small groups with core practices to apply the principles of SMART.
Eligibility Criteria
You may qualify if:
- Attending the Mayo Clinic Depression Center and Behavioral Health Clinic at Mayo Clinic Health System, Austin, Minnesota
- DSM-V diagnostic confirmation of major depressive disorder (MDD)
- Baseline PHQ-9 scores in the range of ≥6-≤19, and HAMD-17 score 8-18, or QIDS-C16 score of 6-20
- Able to speak English
- Participants will continue taking any prescribed medications from their clinical treatment team
- Patients with co-morbid secondary diagnoses of persistent depressive disorder and generalized anxiety disorders will be included in the study.
You may not qualify if:
- Participants with bipolar disorder
- Active psychosis
- Active suicidal ideations
- Active substance abuse meeting criteria for substance use disorders except nicotine
- Obsessive compulsive disorder
- Active Panic disorder with agoraphobia, other phobic disorder
- Active Posttraumatic stress disorder
- Active Severe personality disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
Related Publications (1)
Seshadri A, Clark MM, Kung S, Fuller-Tyszkiewicz M, Sood A, Dammen KC, Rico JA, Tye SJ, McGillivray J, Frye MA. Feasibility Study of Stress Management and Resiliency Training (SMART) in Patients With Major Depressive Disorder. Prim Care Companion CNS Disord. 2020 Apr 30;22(3):19m02556. doi: 10.4088/PCC.19m02556.
PMID: 32369689DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ashok Seshadri, M.D.
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant, Instructor in Psychiatry
Study Record Dates
First Submitted
September 6, 2017
First Posted
September 8, 2017
Study Start
November 29, 2016
Primary Completion
July 1, 2018
Study Completion
October 15, 2018
Last Updated
November 14, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share